S-1: General form for registration of securities under the Securities Act of 1933
PRE 14A: Preliminary proxy statements relating to merger or acquisition
8-K: Current report
8-K: Current report
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(5.10%),Steven Boyd(5.10%)
10-Q: Q3 2024 Earnings Report
8-K: Current report
8-K: Current report
8-K: Current report
10-Q: Q2 2024 Earnings Report
8-K: Current report
S-3: Registration statement for specified transactions by certain issuers
8-K: Current report
8-K: Current report
10-Q: Q1 2024 Earnings Report
10-K/A: Annual report (Amendment)
10-K/A: Annual report (Amendment)
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WRIGHT TIMOTHY R
Protagenic Therapeutics | 10-K: FY2023 Annual Report
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Stein Robert Benjamin
Unlock the Full List